CHARLES M. BAUM - 04 Jan 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
President,Founder,Head of R&D, Director
Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Jan 2022
Net transactions value
-$607,855
Form type
4
Filing time
06 Jan 2022, 15:51:29 UTC
Previous filing
17 Dec 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $597,568 -4,045 -3.8% $147.73 101,239 04 Jan 2022 Direct F1
transaction MRTX Common Stock Sale $10,287 -69 -0.07% $149.08 101,170 04 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.